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Background: Sleep quality and psychological well being of parents are expected to be influenced by the child's health and disease status. The aim
of this study was to compare sleep quality and depression–anxiety parameters in mothers of children with cystic fibrosis (CF) asthma and healthy
controls.
Methods: The study included mothers of 62 children with asthma, 21 children with CF and 35 healthy children. All mothers filled in the Pittsburgh
Sleep Quality Index (PSQI) questionnaire and hospital anxiety depression scale (HADS).
Results: Comparison of the three groups with Kruskall Wallis analysis demonstrated that subjective sleep, sleep efficiency and total PSQI scores
were significantly different between the groups (p=0.02, p=0.01 and p=0.04 respectively). Comparisons of the groups in pairs with Mann
Whitney U test with Bonferroni correction revealed that subjective sleep quality scores in mothers of children with asthma were significantly
higher than the ones in the control group (1.0±0.9 vs 0.6±0.7, p=0.015). The other PSQI scores as well as the anxiety and depression scores were
higher in CF and asthma groups when compared to the control group but did not reach statistical significance. Anxiety and depression scores were
significantly correlated with PSQI total score in CF (rho=0.54 and 0.49 respectively) and asthma groups (rho=0.45 and 0.60 respectively) but not
in the control group.
Conclusion: In conclusion, presence of a chronic respiratory disease in a child may be associated with disturbed sleep quality and increased
depression and anxiety in mothers.
© 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Sleep quality; Depression; Anxiety; Cystic fibrosis; Asthma1. Introduction
Parents as caregivers of children are expected to be
influenced by the child's health and disease status therefore
both mood and sleep disturbances may be observed in
caregivers of children with chronic disease [1,2]. This might☆ The preliminary results of this paper were presented as a poster in ECFS
2007 Annual Conference in Antalya, Turkey with the title “Comparison of sleep
quality, anxiety and depression between mothers of children with cystic fibrosis
and with asthma”.
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doi:10.1016/j.jcf.2008.05.002be attributed both to the task of caring and to the associated
responsibility [3]. Moreover, sleep quality has been reported to
be related to mood and stress [4]. There is a two sided influence
between child and the mother considering that the caregivers'
psychological status influences the child's care [5]. Therefore,
evaluation of mood and sleep patterns in caregivers of children
with chronic diseases is important not only for the mother but
also for the care of the child. This kind of an influence might be
expected to be more intense for mothers of children with
diseases like CF that have a grave prognosis without a complete
cure when compared to other chronic diseases with a less grave
prognosis. On the other hand, any chronic disease in a child
might stress the mother sufficient to cause disturbance. Moodd by Elsevier B.V. All rights reserved.
496 O. Yılmaz et al. / Journal of Cystic Fibrosis 7 (2008) 495–500has two aspects that include anxiety and depression because
both have been found to be associated with a chronic disease in
the child and both can be addressed and improved by a support
program [6]. There is no study that compares mood and sleep
disorders in mothers of children with two different chronic
respiratory disorders that require long term treatment [7].
Treatment of CF, that is the most common hereditary multi-
systemic and progressive disease in white individuals, includes
a complex regimen of airway clearance, aerosols, pancreatic
enzymes, antibiotics and dietary supplements [8–10]. Similarly,
asthma is one of the most common chronic diseases of
childhood and requires long term treatment with inhaled
medications [11,12]. Caring for a family member takes a large
part of the caregivers day and sometimes night, so might lead to
sleep problems in the caregiver [1]. Thus, chronic illness like
CF and asthma in a child may influence sleep patterns and may
lead to anxiety and depression in mothers who are mostly the
primary caregivers in our cultural background [2].
Therefore the aim of this study was to compare sleep quality
and depression–anxiety parameters in children with CF and
asthma as two different chronic respiratory diseases requiring
chronic treatment and in healthy children.
2. Methods
2.1. Subjects
The study included mothers of 62 children with asthma (33
male, 29 female; mean age 8.1±2.9 years) and 21 children with
CF (12 males 9 females; mean age 6.1±4.6 years) followed up
in our department and mothers of 35 healthy children (24 male,
11 female; mean age 8.8±3.4 years) who had come for healthy
child visit to the Pediatrics outpatient department. Mothers of all
the children with CF and mothers of those with asthma who
presented to the outpatient department during the duration of the
study and agreed to fill in the questionnaires were included.
Healthy subjects were again included in the order they
presented. Socio-demographic characteristics were similar
between the three groups. Exclusion criteria included not
accepting to participate in the study, chronic physical or
psychological disorder of the mother or someone else in the
family.
At the start of the study, fathers were to be included however,
most fathers did not complete the questionnaire. Most children
were brought to the hospital by mothers and the questionnaires
sent home for the fathers were not brought back. Therefore, the
study was continued only on mothers.
2.2. Study design
All mothers included in the study were asked to fill in the
Turkish versions of Pittsburgh Sleep Quality Index (PSQI)
questionnaire and hospital anxiety depression scale (HADS)
[13–15]. Mothers were seen by the pediatrician in charge of
the study during the time they filled in the questionnaires.
Socio-demographic characteristics like education were also
recorded.The study was approved by the ethical committee of Celal
Bayar University Medical Faculty.
2.3. Evaluation of sleep quality
Pittsburgh Sleep Quality Index measures sleep disturbance
over the previous month. It consists of 19 items evaluated over 7
domains that include subjective sleep quality, sleep latency,
sleep duration, habitual sleep efficiency, sleep disturbance, use
of sleep medications and daytime dysfunction [16]. Domains
are scored on a scale 0 to 3 where 3 indicates severe impairment.
Overall PSQI score is calculated by adding scores for all
domains to range from 0 to 21 where 21 indicates severe
impairment [16]. Healthy sleep is recognized in individuals with
a total PSQI score of 0 to 5, bad sleep in the ones with a total
PSQI of 6–10. The scores above 10 indicate a chronic sleep
disorder.
2.4. Evaluation of anxiety and depression parameters
Anxiety and depression parameters were tested by the
Turkish version of HADS questionnaire which includes 14
questions, eight of which are scored from 3 to 0 and six are
scored from 0 to 3. The anxiety subscore is measured by
adding up seven items and the depression subscore is
calculated by adding up the remaining seven items. As the
scores increase, depression and anxiety increase. HADS was
used in this study although the mothers did not have a
physical illness because sleep disturbance of the mother
might have physical consequences like fatigue and sleepi-
ness. Therefore we did not want to include a measurement of
somatic symptoms of depression.
2.5. Statistical analysis
Statistical analyses were performed by SPSS 13.0 (Chicago
IL) computer program. Parameter values were reported by
mean±standard deviation (SD) and group differences. Kruskall
Wallis test was used to compare mean values of PSQI and
HADS scores of the groups. Then a Mann Whitney U test was
performed for comparison of the groups in twos. One of the
reasons for using nonparametric tests was that the number of the
mothers in the CF group was too small to assume central limit
theorem applied. For comparison of asthma and control groups,
although the number of subjects included were not small, the
results were quite widely distributed. Similarly the Mann
Whitney U test was used to compare the ages of the children
included in the study. Pearson's Chi Square test was used to
compare the frequencies of healthy and poor sleep and chronic
sleep disorder in the three groups. For each group PSQI, anxiety
and depression scores were put into linear regression model
taking PSQI total score as the dependent variable.
p values less than 0.05 were regarded as statistically
significant except for the comparison of the pair of groups
using the Mann Whitney U test when Bonferroni's correction
was applied to the statistics and p values less than 0.018 were
regarded as statistically significant to reduce type 1 error.
Fig. 1. Comparison of sleep disturbance frequencies in children with CF, those
with asthma and healthy controls.
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3.1. Socio-demographic characteristics
Comparison of the ages of children with CF with the ages of
those in the control and asthma groups did not reveal a
statistically significant difference with Mann Whitney U test
(p=0.09 and p=0.07 respectively). Similarly age means of the
children included in asthma and control groups were not
significantly different either (p=0.54) (Table 1).
Maternal education was not significantly different between the
groups (Chi square=5.9, p=0.21). Among the control group,
44.1% had less than or equal to 8 years of education, while 41.2%
had finished high school and 14.7% had university education.
Among the asthma group, 64.5%had less than or equal to 8 years of
education, 29% had high school education and 6.5% had graduated
from a university. In the CF group 71.4% had less than or equal to
8 years of education while 19% had graduated from high school
and 9.6% had graduated from a university (Table 1).
3.2. Sleep quality scores
Comparison of the three groups with Kruskall Wallis analysis
demonstrated that subjective sleep, sleep efficiency and total PSQI
scores were significantly different between the groups (p=0.02,
p=0.01 and p=0.04 respectively) (Table 1). Comparison of the
groups in pairs with Mann Whitney U test demonstrated that
although subjective sleep quality score in the CF group was higher
than that in the control group, but p values did not reach
significance after Bonferroni's correction (mean±SD 1.1±0.9 vs
0.6±0.7 respectively, p=0.03) (Table 1). Similarly, total PSQI
score was higher in the CF group when compared to the control
group but was not statistically significant (4.6±2.4 vs 3.2±1.6
respectively, p=0.04) (Table 1). There was no statistically
significant difference in any of the sleep parameters between CF
and asthma groups (p=0.03 for sleep efficiency and pN0.05 for all
other scores of PSQI (Table 1). Subjective sleep quality scores in
mothers of children with asthma was significantly higher than the
ones in the control group (1.0±0.9 vs 0.6±0.7,p=0.015) (Table 1).
Total PSQI score in the asthma group was higher than the control
group but did not reach statistical significance (4.8±2.8 vs 3.2±1.6,
p=0.025).Table 1
Sociodemographic characteristics of the children and mothers included in the
CF, asthma and control groups
CF Control Asthma p⁎
(n=21) (n=35) (n=62)
Children
Gender Male 12 (57.1)⁎ 24 (68.6) 33 (53.2) N0.05
Female 9 (42.9) 11 (31.4) 29 (46.8)
Age (years) 6.1±4.6 8.8±3.4 8.1±2.9 0.54
Mother
Education ≤8 years 15 (71.4) 15 (44.1) 40 (64.5) 0.21
High school 4 (19) 14 (41.2) 18 (29)
University 2(9.6) 5 (14.7) 4(6.5)
⁎Values in parenthesis indicate percentages.It was demonstrated that the frequency of healthy sleep in
mothers of theCFgroup and in those of the asthmagroupwere 70%
and 62.5% respectively while the frequencies of poor sleep were
30% and 35.4% in the two groups respectively (p=0.72, Pearson
Chi Square=0.66). All themothers in the control group had healthy
sleep and this was significantly different from the CF and asthma
groups (Pearson Chi Square=8.97, p=0.003 with Fisher's exact
test and Pearson Chi Square=12.9, p=0.002 respectively) (Fig. 1).
3.3. Anxiety and depression parameters
Comparison of anxiety score between the three groups with
Kruskall Wallis analysis did not reveal a statistically significant
difference but the scores were higher in CF and asthma groups
(8.0±4.2 in CF, 8.4±4.3 in asthma and 6.7±2.5 in the control
groups, p=0.19) (Table 2).
Depression subscorewas not statistically significant between the
three groups when tested with Kruskall Wallis analysis but the
scores in CF and asthma groups were higher than that in the control
group (6.5±3.8 in the CF, 6.5±3.9 in asthma and 4.6±2.3 in
control groups, p=0.05) (Table 2).
3.4. Correlation of sleep quality and depression–anxiety
parameters
Correlation analysis of the sleep quality parameters with
depression–anxiety scores using the Spearman's correlation test
did not reveal a statistically significant correlation between
PSQI total or subscores and anxiety or depression in the control
group (pN0.05 for all) (Figs. 2 and 3). However, there was a
positive correlation between subjective sleep score and anxiety
score (rho=0.30, p=0.09). In other words, as subjective sleep
quality deteriorated, anxiety increased in mothers of the control
group. However, there was no correlation between depression
score and sleep quality total or domain subscores (pN0.05).
In mothers of the asthma group, anxiety subscore was
significantly positively correlated with total PSQI score
(rho=0.45, p=0.002) (Fig. 2) as well as the subjective sleep
quality (rho=0.60, p=0.00), sleep disturbance (rho=0.28,
p=0.04) and daytime dysfunction (rho=0.44, p=0.001) scores
with the Spearman's correlation test. Similarly, depression
subscore of this group showed significantly positive correlation
Fig. 3. Scatter plot of the correlation between total PSQI scores and
depression scores in all the groups.Linear regression equations for the control group
is y=3.40−(0.02)⁎depression, for the asthma group is y=2.68+(0.33)⁎depression,
for the CF group is y=2.38+(0.34)⁎depression.
Table 2
Pittsburgh quality of life index scores and anxiety–depression scores in mothers
of the CF, asthma and control groups (mean±standard deviation)
CF Control Asthma p⁎
(n=21) (n=35) (n=62)
Subjective sleep quality 1.1±0.9 0.6±0.7 1.0±0.9 0.02
Sleep latency 1.1±0.8 0.7±0.6 0.8±0.8 0.24
Sleep duration 0.6±0.8 0.3±0.6 0.5±0.9 0.31
Sleep efficiency 0.1±0.3 0.1±0.4 0.6±1.0 0.01
Sleep disturbance 0.9±0.7 0.9±0.4 0.9±0.7 0.86
Use of hypnotics 0.0±0.0 0.0±0.2 0.1±0.5 0.39
Daytime dysfunction 0.9±0.9 0.8±0.8 1.2±1.0 0.29
PSQI total score 4.6±2.4 3.2±1.6 4.8±2.8 0.04
Anxiety score 8.0±4.2 6.7±2.5 8.4±4.3 0.19
Depression score 6.5±3.8 4.6±2.3 6.5±3.9 0.05
⁎Kruskall Wallis analysis.
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sleep quality (rho=0.56, p=0.00) and daytime dysfunction
subscores (rho=0.39, p=0.003).
In mothers of the CF group, anxiety subscore was
significantly correlated with total PSQI score (rho=0.54,
p=0.01) (Fig. 2), subjective sleep quality (rho=0.56, p=0.01)
and sleep latency subscore (rho=0.53, p=0.02) when tested
with Spearman's correlation test. Depression subscore was also
significantly correlated with total PSQI score (rho=0.49,
p=0.03) (Fig. 3) and subjective sleep quality subscore
(rho=0.63, p=0.002).
These correlations indicate that as sleep quality parameters
deteriorate anxiety and depression increase in the CF and
asthma groups.
4. Discussion
A substantial amount of time is spent by parents caring for
children with chronic diseases [3]. Both the stress and the
responsibility of having a child with a chronic disease, with all
the worries and fears it brings about and the task of caring itself
might disturb the sleep quality of the parents [3]. The extent to
which this disturbance occurs with different chronic diseases
may vary, therefore the aim of this study was to compare theFig. 2. Scatter plot of the correlation between total PSQI scores and anxiety
scores in all the groups. Linear regression equations for the control group is
y=3.77− (0.08)⁎anxiety, for the asthma group is y=2.39+(0.29)⁎anxiety, for
the CF group is y=2.02+(0.32)⁎anxiety.extent of impairment in mothers of children with two different
chronic respiratory diseases. CF and the intensive treatment
modalities indicated in patients with CF increase the burden of
disease itself in children and their caregivers [3]. Similar to CF,
asthma a common chronic disease of the respiratory tract in
children is characterized by requirement of long term treatment
[11]. Therefore, sleep quality and depression–anxiety para-
meters were studied in mothers of children with CF and asthma.
Sleep quality of a child was reported to influence sleep
quality of mothers in a previous study [7]. An ill child with
disturbed sleep would be expected to need more attention and
care at night when compared to a child who sleeps undisturbed.
There have been many previous studies demonstrating sleep
quality impairment in patients with CF, both due to the
complications of the respiratory tract and time consuming
treatment modalities [4,9,17,18]. In children with CF, a wrist
actigraphic study demonstrated that self perceived sleep quality
was poor and sleep fragmentation was extensive [9]. Similarly,
polysomnography showed that sleep onset and maintenance
problems as well as reported day-time sleepiness were more
common in children with CF and sleep efficiency was decreased
when compared to healthy children [18]. Moreover, total PSQI
scores of children with CF were found to be higher than healthy
controls and healthy sleep frequency was reported to be
significantly lower [9]. Therefore, sleep disorder in a child
might influence the sleep quality of the caregiver, too,
explaining in part the results of our study in which we detected
significantly reduced total PSQI score in mothers of children
with CF and those with asthma when compared to the mothers
of healthy controls. This decrease in sleep quality might be
attributed to a couple of reasons including the burden of caring
for a diseased child, stress of having an ill child and the presence
of a possible sleep disturbance in the child himself, as explained
above.
In a previous study, it was detected that treatment of children
with CF took a much longer time when compared to children
with asthma probably due to the complexities of treatment [3].
Considering that CF is a progressive disease that shortens the
life expectancy of the child and that the treatment of CF is more
complex, mothers of children with CF might be expected to be
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child. This may lead to poorer sleep quality and higher
depression–anxiety when compared to mothers of asthmatic
and healthy children. However, asthma in a child was also
previously reported to impair sleep quality and increase
anxiety–depression symptomatology of mothers when com-
pared to mothers of healthy children. It was shown that
nocturnal asthma symptoms in children were associated with
missed work days in parents [2,19]. This was similar to the
results of another study that demonstrated poorer sleep
efficiency in caregivers of children with CF when compared
to the caregivers of healthy children [1]. Sleep quality total
score and subjective sleep quality score point out a significantly
reduced sleep quality in mothers of children with asthma and
CF when compared to those mothers with healthy children
according to the results of our study. However, the difference
between mothers of children with CF and asthma was not found
to be significantly different except poorer sleep efficiency in
mothers of asthmatics. This is an important result in
demonstrating that the presence of a chronic disease in the
child disturbs sleep of mothers to similar extent in different
groups of diseases. This similarity may be attributed in part to
the fact that the presence of a chronic disease in a child stresses
and disturbs the mother irrespective of the nature of the disease
itself whether its prognosis is grave as in CF or less debilitating
as in asthma.
It has been reported that the frequency of depression and
anxiety is higher in mothers of children with chronic diseases
[1]. The frequency of mild depression was found to be higher in
mothers of young children with CF when tested with Beck's
depression inventory [20]. This frequency was found to
decrease after 9 months demonstrating the possible influence
of facing a new diagnosis of CF in a child [20]. In a previous
study comparing parental depression in children with CF
diagnosed early or later in life, it was reported that 17% of
mothers of children diagnosed early and 26% of mothers of
children diagnosed late felt hopeless [21]. In mothers of
children newly diagnosed with CF, parenting stress is found to
be increased and they report greater difficulty in the caregiver
role. Moreover, rates of depression were higher in those mothers
[22]. Frequency of dysphoria or mild depression in mothers of
children who were diagnosed with CF within the last 3 months
was found to be 44% which was higher than the 35% in the
mothers of children without CF [20]. Similarly, mothers of
children with asthma were shown to have higher depression and
anxiety levels when compared to mothers of healthy children
[2]. The results of our study demonstrate higher depression
scores in mothers of children with CF and those with asthma
when compared to the mothers of healthy controls as expected.
However one important point from this study is that anxiety and
depression scores are similar between mothers of children with
asthma and those with CF. This adds to the evidence that a
chronic disease in a child causes a distress to the mother
affecting her psychological status irrespective of the nature of
the disease.
When the two above mentioned influences of chronic disease
in a child, namely sleep disturbance and anxiety–depression areevaluated together another important aspect of the results of our
study become evident. That is the relationship between sleep
quality and depression–anxiety parameters. Maternal sleep
quality has been reported to be a significant predictor of
maternal mood, stress, and fatigue [7]. Moreover, a previous
study on caregivers of children with CF and those with
ventilator dependency, found that sleep quality of the caregivers
mediated the relationship between child health and depression
of the caregiver [1]. Supporting this idea, the results of our study
demonstrate a significant correlation of total PSQI score and
subjective sleep quality subscore with depression–anxiety
subscores in both mothers of children with asthma and CF but
not in mothers of healthy controls. These results indicate that
maternal sleep quality has an important influence on maternal
mood or vice versa, parental mood (which is expected to be
influenced by the presence of a chronic disease in a child)
disturbs sleep in the mother. The direction of this relationship is
hard to determine in a cross sectional study and not vital for
evaluation and intervention. Sleep quality and psychological
problems seem to be integrated in mothers of children with
chronic diseases therefore improvement in one can be expected
to help improvement in the other.
The importance of detection of depressive symptomatology
in the mothers as primary caregivers of children lies in the fact
that it has been reported to influence medication adherence. In a
study about mothers of children with asthma, it was shown that
depression decreased medication adherence and increased
emergency department visits [5]. Moreover, they were more
dissatisfied with treatment which might be a factor for
decreased adherence [5]. It was also seen that depression and
poor adherence were independently associated with more
frequent asthma symptoms [5]. It has been reported that
complexity of a treatment regimen influences adherence to
treatment negatively in asthma and CF patients [23]. Consider-
ing this, it may be concluded that parental depression might
influence treatment and patient outcome greatly in CF patients
who are on a complex regimen of therapy. Moreover, family
relationship quality influences medication adherence of older
children and adolescents with CF [24]. Caregiver mood is not
only important for medication adherence but also for global
development of the child as a bio-psycho-social creature who is
to be evaluated first as a child then as a patient with an illness.
The aspect of development is an issue that makes the ill child
unique from the adult patient. A psychologically disturbed
mother with poor sleep may not be expected to contribute to the
development of her child. These findings point out the
importance of monitoring for maternal psychological status
for pediatric patients. Detection of mothers with mood and sleep
disturbance might be included in a psychosocial support
program with the help of a psychiatrist and psychologist to
improve their status.
One of the main limitations of this study was failure to
include the fathers which was planned in the initial study
design. This could have allowed comparison of the influence of
the chronic disease in a child on two parents. However, most
children are brought to our department by their mothers and
questionnaires were not returned by most fathers. There were
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analysis. Therefore, it was excluded from the final design.
Another limitation was that, sleep and mood may be influenced
by many other factors that were not identified in the study.
Although, some socio-demographic characteristics were
included, this could have been more detailed. Information
regarding familial history of sleep disturbance and mood
disorders were asked but many people have other subclinical
disorders which may not have been identified.
In conclusion, presence of a chronic respiratory disease in a
child may be associated with a deterioration in sleep quality in
mothers as well as increased depression and anxiety. The extent
of this deterioration seems to be similar in CF and asthma,
indicating that it is not the characteristics of the condition itself,
but the presence of a chronic disease that influences the sleep
and psychological status of the mother. Moreover, sleep and
anxiety–depression parameters influence each other. The
direction of this relationship is controversial but probably a
two sided influence exists, sleep disturbance and anxiety–
depression aggravating each other. Maintaining efficacy of care-
giving requires effective support of these factors for mothers of
children with chronic respiratory diseases. Moreover, healthy
psychosocial development of a child depends on a healthy
interaction with the mother. Therefore, assessment of mothers of
children with CF and asthma for sleep and mood disorders and
treatment when necessary may be regarded as an essential part
of child care. Further research assessing the results of a
psychosocial support program for mood and sleep disorders in
mothers of children chronic disorders is needed in the light of
the results of the current study.
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